Clinical Trial Update: Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing bladder instillations to onabotulinumtoxinA for interstitial cystitis/bladder pain syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Status: COMPLETED